DXCM
DexCom, Inc.
NASDAQ · USHealthcareMedical - Devices
$75.69-1.25%
Price as of Jul 20, 2026
DXCM profitability
DexCom, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 61.8%
- EBITDA margin
- 30.6%
- EBIT margin
- 21.4%
- Net margin
- 19.3%
- Free cash flow margin
- 29.7%
Returns
- Return on equity
- 31.5%
- Return on assets
- 14.0%
- Return on invested capital
- 23.8%
- Asset turnover
- 0.74x
Cash efficiency
- Cash from operations
- $1.8B
- Cash per share
- $6.26
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.